MedElevator Войти в исследования
← Поиск публикаций

DOI 10.17219/acem/104544

Медицинская библиотека · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2019

Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.

Olukman Murat, Can Cenk, Coşkunsever Deniz, Uyanikgil Yiğit, Çavuşoğlu Türker, Sözmen Eser, Duman Soner, Çelenk Fatma Gül, Ülker Sibel

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cyclosporine-A (CsA) is widely used for immunosuppressive therapy in renal transplantation. Nephrotoxicity is the main dose-limiting undesirable consequence of CsA. Urotensin II (U-II), a novel peptide with a powerful influence on vascular biology, has been added to the list of potential renal vascular regulators. Upregulation of the urotensin receptors and elevation of plasma U-II levels are thought to possibly play a role in the etiology of renal failure.

OBJECTIVES

The present study examines this hypothesis by evaluating renal function and histology with regard to the potential role of U-II and its antagonist, palosuran, in the pathogenesis of CsA-induced nephrotoxicity in rats.

MATERIAL AND

METHODS

Male Sprague-Dawley rats were treated with CsA (15 mg/kg, for 21 days, intraperitoneally) or CsA + palosuran (300 mg/kg, for 21 days). Renal function was measured and histopathology, U-II immunostaining and protein detection with western blotting of the kidneys were performed.

RESULTS

Cyclosporine-A administration caused a marked decline in creatinine clearance (Ccr). Fractional sodium excretion (FENa) tended to increase in the CsA-treated rats. Plasma U-II levels decreased in the CsA-treated rats. Cyclosporine-A treatment resulted in a marked deterioration in renal histology and an increase in the expression of U-II protein in the kidneys. Palosuran's improvement of renal function manifested as a significant decrease in serum creatinine levels and a significant increase in urine creatinine levels, resulting in a marked increase in Ccr. Palosuran produced a significant normalization of kidney histology and prevented an increase in U-II expression.

CONCLUSIONS

Cyclosporine-A-induced renal impairment was accompanied by an increase in U-II expression in kidneys and a contrary decrease in systemic U-II levels. Palosuran improved the condition of rats suffering from renal dysfunction by preventing the decrease in renal U-II expression without affecting the systemic levels of U-II. The protective effect of palosuran in CsA nephrotoxicity is possibly independent of its U-II receptor antagonism.

Для цитирования: Olukman Murat, Can Cenk, Coşkunsever Deniz, Uyanikgil Yiğit, Çavuşoğlu Türker, Sözmen Eser, Duman Soner, Çelenk Fatma Gül, Ülker Sibel. Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2019. DOI: 10.17219/acem/104544.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.